Attaining ‘commercial agility’ in data management

It’s common knowledge that most life sciences organizations today are getting better at managing their internal files of customer master data—the names, locations and affiliations of prescribers and other influences on therapy choices. The data is more accessible than ever, […]

Read More

Powering up medical affairs

In a world where health systems are increasingly focused on value-based pricing and personalized treatments, the heightened emphasis on scientific exchange between the pharmaceutical, biotech, medical device and diagnostic industry and its customers has never been greater. The perception that […]

Read More

IMS Health and Reltio tighten their collaboration

Choose your buzzword: Big Data, MDM, SaaS or PaaS; the upshot of the just-announced partnership should be that life sciences companies will have an easier time blending their commercial data resources to provide better sales support and better market analytics. […]

Read More

FDA looks to industry for help in DSCSA compliance

Although pharma manufacturers and contract packagers are ramping up their capital-equipment purchases to meet the November 2017 deadline for having item-level serialization, many aspects of the Drug Supply Chain Security Act (DSCSA) remain unresolved. Some of these are operational issues […]

Read More

Prepaid cash cards motivate clinical trial patients

As the pharma industry makes its peace with the US Physicians Sunshine Act and regulatory reporting of “transfers of value” to healthcare providers—and as the same sort of transparency rules are coming into force in Europe—another transactional channel is getting […]

Read More